Gibraltar Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Gibraltar Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-60,829	Closed	-$2.8M	–	33
2016 Q3	$2.8M	Sell	60,829 -557	-0.9%	-$29.1K	3.23%	20
2016 Q2	$3.08M	Sell	61,386 -827	-1%	-$44K	3.79%	15
2016 Q1	$3.33M	Buy	62,213 +4,663	+8%	+$274K	4.48%	14
2015 Q4	$3.78M	Sell	57,550 -574	-1%	-$35.5K	4.69%	8
2015 Q3	$3.28M	Buy	58,124 +3	+0%	+$195	4.06%	11
2015 Q2	$3.44M	Sell	58,121 -37,463	-39%	-$2.31M	3.66%	10
2015 Q1	$5.96M	Sell	95,584 -556	-0.6%	-$32.3K	5.64%	1
2014 Q4	$5.53M	Buy	+96,140	New	+$5.36M	4.96%	4

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Gibraltar Capital Management's TEVA Position: Q4 2016 in Review

Gibraltar Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 60,829 shares — an estimated $2.8M sold.

Gibraltar Capital Management first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $5.96M in Q1 2015. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Gibraltar Capital Management reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Gibraltar Capital Management sold 60,829 Teva Pharmaceuticals shares in Q4 2016, an estimated $2.8M.
Gibraltar Capital Management first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 8 quarters.
Gibraltar Capital Management's Teva Pharmaceuticals position peaked at $5.96M in Q1 2015.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Gibraltar Capital Management's 13F filing for Q4 2016, filed 18 Jan 2017.